Tested GH
Tested GH, licence 80042595: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Supplement Facts Inc. / Canada 3587843 Inc.
- NPN or DIN-HM
- 80042595
- Status
- Active licence
- Licence date
- 31 May 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 300.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose microcristalline, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
L-Arginine is a non-essential amino acid that is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. If you have been diagnosed with a neurological disorder or a cardiovascular disorder, consult a health care practitioner prior to use. Nausea, constipation, insomnia, restlessness, agitation and headache, and dizziness have been known to occur
Source
Official Health Canada record, licence 80042595
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.